Total
0
Shares
Little Green Pharma (ASX:LGP) - Managing Director, Fleta Solomon - The Market Herald
Managing Director, Fleta Solomon
Sourced: AUManufacturing
  • Medicinal cannabis company Little Green Pharma (LGP) has been granted a new manufacturing permit from the office of drug control
  • The manufacturing permit will allow the company to manufacture cannabis extracts for holders of Therapeutic Goods Administration (TGA) GMP manufacturing licences to produce medicinal cannabis products
  • The company is now waiting on the medicinal cannabis cultivation and production permit, which will allow Little Green to begin planting at its expanded facility
  • Little Green is up 19.4 per cent on the market today and is trading for 40 cents per share

Medicinal cannabis company, Little Green Pharma (LGP) has been granted a new manufacturing permit from the office of drug control.

The manufacturing permit will allow the company to manufacture cannabis extracts for holders of therapeutic goods administration (TGA) GMP manufacturing licences to produce medicinal cannabis products.

Little Green has an exclusive agreement with its GMP-licenced manufacturing partner to produce the products.

The permit is valid for one year and ends in March 2021. This new permit will also allow the company to commence in-house extraction once the next crop is harvested, which is set to reduce costs and improve efficiencies.

Managing Director Fleta Solomon said receiving this permit also gives the company the capability to manufacture cannabis extracts at its manufacturing premises.

"We are now only waiting for our expanded ODC Medicinal Cannabis Cultivation and Production Permit which, once granted, will allow us to begin first planting at our expanded cultivation facility and to significantly expand our production operations," she said.

"This increased production capacity will give Little Green Pharma the ability to meet both Australian and offshore demand for medicinal cannabis products," Fleta added.

The company is now waiting on the medicinal cannabis cultivation and production permit, which will allow Little Green to begin planting at its expanded facility.

Little Green is up 19.4 per cent on the market today and is trading for 40 cents per share at 1:03 pm AEST.


Subscribe


LGP by the numbers
More From The Market Herald
ResApp Health (ASX:RAP) - CEO & Managing Director, Tony Keating - The Market Herald

" ResApp (ASX:RAP) to licence cough-counting app to AstraZeneca Japan

ResApp (RAP) has struck a deal with global biotech giant AstraZeneca to use ResApp smartphone software in a lung cancer clinical study.
RooLife Group (ASX:RLG) - Managing Director, Bryan Carr - The Market Herald

" RooLife Group (ASX:RLG) and AFT Pharmaceuticals (ASX:AFP) launch Kiwi Health in China

RooLife Group (RLG) and AFT Pharmaceuticals (AFP) have launched a New Zealand-branded online health and pharmacy store in China.
Opthea (ASX:OPT) - CEO & Managing Director, Dr Megan Baldwin - The Market Herald

" Opthea (ASX:OPT) raises A$180.3M following NASDAQ IPO

Opthea (OPT) has completed its initial public offering to list on the United States’ NASDAQ stock exchange.
Immutep (ASX:IMM) - CEO, Marc Voigt - The Market Herald

" Immutep (ASX:IMM) granted European patent for IMP761

Immutep (IMM) has been granted a European patent for IMP761, an anti-LAG-3 antibody.